These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 27564431

  • 1. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN, Bergman MJ, Yourish J, Pei J, Reiss W, Keystone E.
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [Abstract] [Full Text] [Related]

  • 2. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
    Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T.
    J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
    [Abstract] [Full Text] [Related]

  • 3. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
    Castrejón I, Dougados M, Combe B, Fautrel B, Guillemin F, Pincus T.
    J Rheumatol; 2016 Jul; 43(7):1285-91. PubMed ID: 27084913
    [Abstract] [Full Text] [Related]

  • 4. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
    Kaneko Y, Kondo H, Takeuchi T.
    J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
    [Abstract] [Full Text] [Related]

  • 5. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
    Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M.
    Ann Rheum Dis; 2011 Mar; 70(3):404-13. PubMed ID: 21292833
    [Abstract] [Full Text] [Related]

  • 6. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes.
    Ruyssen-Witrand A, Guernec G, Nigon D, Tobon G, Jamard B, Rat AC, Vittecoq O, Cantagrel A, Constantin A.
    Ann Rheum Dis; 2015 Sep; 74(9):1676-83. PubMed ID: 24794151
    [Abstract] [Full Text] [Related]

  • 7. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
    Mack ME, Hsia E, Aletaha D.
    Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
    [Abstract] [Full Text] [Related]

  • 8. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
    Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M, American College of Rheumatology, European League Against Rheumatism.
    Arthritis Rheum; 2011 Mar; 63(3):573-86. PubMed ID: 21294106
    [Abstract] [Full Text] [Related]

  • 9. Do Short and Sustained Periods of American College of Rheumatology/European League Against Rheumatism Remission Predict Functional and Radiographic Outcome in Early Rheumatoid Arthritis Patients With Low Overall Damage Progression?
    Konijn NPC, van Tuyl LHD, Boers M, den Uyl D, Ter Wee MM, Kerstens P, Voskuyl AE, van Schaardenburg D, Nurmohamed MT, Lems WF.
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):989-996. PubMed ID: 27696732
    [Abstract] [Full Text] [Related]

  • 10. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
    Barnabe C, Homik J, Barr SG, Martin L, Maksymowych WP.
    J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
    [Abstract] [Full Text] [Related]

  • 11. Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study.
    Uhlig T, Lie E, Norvang V, Lexberg ÅS, Rødevand E, Krøll F, Kalstad S, Olsen IC, Kvien TK.
    J Rheumatol; 2016 Apr; 43(4):716-23. PubMed ID: 26879358
    [Abstract] [Full Text] [Related]

  • 12. Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria.
    Shahouri SH, Michaud K, Mikuls TR, Caplan L, Shaver TS, Anderson JD, Weidensaul DN, Busch RE, Wang S, Wolfe F.
    Arthritis Rheum; 2011 Nov; 63(11):3204-15. PubMed ID: 21739423
    [Abstract] [Full Text] [Related]

  • 13. Assessing remission in rheumatoid arthritis on the basis of patient reported outcomes--advantages of using RAPID3/MDHAQ in routine care.
    Castrejón I, Pincus T.
    Bull Hosp Jt Dis (2013); 2014 Nov; 72(2):136-41. PubMed ID: 25150340
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome.
    van Tuyl LH, Britsemmer K, Wells GA, Smolen JS, Zhang B, Funovits J, van Schaardenburg D, Felson D, Boers M.
    Ann Rheum Dis; 2012 Jan; 71(1):33-7. PubMed ID: 21953347
    [Abstract] [Full Text] [Related]

  • 18. American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision.
    Studenic P, Aletaha D, de Wit M, Stamm TA, Alasti F, Lacaille D, Smolen JS, Felson DT.
    Arthritis Rheumatol; 2023 Jan; 75(1):15-22. PubMed ID: 36274193
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
    Smolen JS, Aletaha D.
    Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
    [Abstract] [Full Text] [Related]

  • 20. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL.
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.